{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:38:36Z","timestamp":1791923916429,"version":"4.3.4"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"14","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330015"],"award-info":[{"award-number":["82330015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070262"],"award-info":[{"award-number":["82070262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100446"],"award-info":[{"award-number":["82100446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81991503"],"award-info":[{"award-number":["81991503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81725003"],"award-info":[{"award-number":["81725003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270298"],"award-info":[{"award-number":["82270298"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1801100"],"award-info":[{"award-number":["2023YFA1801100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1801104"],"award-info":[{"award-number":["2023YFA1801104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Dendritic cells (DCs) are closely related to blood pressure (BP) regulation. Mineralocorticoid receptor (MR) is an important drug target for antihypertensive treatment. However, the role of DC MR in the pathogenesis of hypertension has not been fully elucidated. This study aimed to determine the role of DC MR in BP regulation and to explore the mechanism.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Renal biopsy and peripheral blood samples were collected from hypertensive patients (HTN) for immunostaining and flow cytometry. Dendritic cell MR knockout (DCMRKO) mice, DC MR overexpressing (DCMROV) mice, DCMROV\/IL-17A knockout (DCMROV\/IL-17AKO) mice and finerenone-treated C57BL\/6 mice were infused with angiotensin II (Ang II) to establish hypertensive models. Western blotting, chromatin immunoprecipitation, co-immunoprecipitation, and in vivo DC depletion or adoptive transfer were used to delineate the functional importance of DC MR in hypertension development.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Mineralocorticoid receptor antagonists (spironolactone and finerenone) suppressed DC aggregation and activation, as well as hypertension in HTN and mice. Compared with littermate control (LC) mice, dendritic cell MR knockout mice had strikingly decreased BPs and attenuated target organ damage after Ang II infusion. Flow cytometry showed that DC MR deficiency mitigated Ang II-induced DC activation and T helper 17 (Th17) cell differentiation. RNA sequencing revealed that MR-deficient DCs had elevated expression of Plc\u03b21 and Plc\u03b24, knockdown of which reversed the inhibitory effect of MR deficiency on DC activation and Th17 differentiation. Adoptive transfer of MR-deficient DCs protected Ang II-induced hypertension, whereas knockdown of Plc\u03b21\/4 eliminated the protective effects. At the molecular level, MR negatively regulated Plc\u03b21\/4, which recruited SHP-1 to inactivate of Stat5 activity, resulting in enhanced NF-\u03baB activation and Th17 polarization. Furthermore, DCMROV mice manifested more elevated BPs and target organ damage than control mice after Ang II infusion, and these differences were abolished in DCMROV\/IL-17AKO mice. Finally, MR antagonists decreased the aggregation of Th17 in HTN and mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Dendritic cell MR plays important roles in the pathogenesis of hypertension by regulating Th17 through Plc\u03b21\/4\u2013Stat5\u2013NF-\u03baB signalling, and blockade of DC MR is beneficial for treating hypertension.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehae670","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:16:47Z","timestamp":1730809007000},"page":"1335-1351","source":"Crossref","is-referenced-by-count":18,"title":["Dendritic cell mineralocorticoid receptor controls blood pressure by regulating T helper 17 differentiation: role of the Plc\u03b21\/4\u2013Stat5\u2013NF-\u03baB pathway"],"prefix":"10.1093","volume":"46","author":[{"given":"Yong-Li","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine , 241 West Huaihai Road, Shanghai 200030 ,","place":["China"]},{"name":"Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province , 166 North Qiutao Rd, Hangzhou 310000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Institute for Regenerative Medicine, State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, Tongji University School of Medicine , Shanghai 200123 ,","place":["China"]},{"name":"Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology , Shanghai 200125 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Tong","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine , 241 West Huaihai Road, Shanghai 200030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Shang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Huashan Hospital, Fudan University , Shanghai 200040 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Juan","family":"Du","sequence":"additional","affiliation":[{"name":"Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology , Shanghai 200125 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Bai","sequence":"additional","affiliation":[{"name":"Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology , Shanghai 200125 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine , 241 West Huaihai Road, Shanghai 200030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zhen","family":"Lin","sequence":"additional","affiliation":[{"name":"Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology , Shanghai 200125 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine , 241 West Huaihai Road, Shanghai 200030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xia","family":"Lu","sequence":"additional","affiliation":[{"name":"Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology , Shanghai 200125 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Bi","sequence":"additional","affiliation":[{"name":"Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology , Shanghai 200125 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology , Shanghai 200125 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology , Shanghai 200125 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Immune Response and Immunotherapy, Shanghai Institute of Immunity and Infection, University of Chinese Academy of Sciences, Chinese Academy of Sciences , Shanghai 200032 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Cun","family":"Qian","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences , Shanghai 200031 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[{"name":"CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Gu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine , 241 West Huaihai Road, Shanghai 200030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5399-7252","authenticated-orcid":false,"given":"Sheng-Zhong","family":"Duan","sequence":"additional","affiliation":[{"name":"Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province , 166 North Qiutao Rd, Hangzhou 310000 ,","place":["China"]},{"name":"Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology , Shanghai 200125 ,","place":["China"]},{"name":"State Key Laboratory of Transvascular Implantation Devices , The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"2025040709523498400_ehae670-B1","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as cardiovascular risk factor in chronic kidney disease","volume":"132","author":"Burnier","year":"2023","journal-title":"Circ Res"},{"key":"2025040709523498400_ehae670-B2","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S2214-109X(22)00428-4","article-title":"Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional study","volume":"11","author":"China PEACE Collaborative Group","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2025040709523498400_ehae670-B3","doi-asserted-by":"publisher","first-page":"e071952","DOI":"10.1136\/bmj-2022-071952","article-title":"Prevalence, awareness, treatment, and control of hypertension in China, 2004\u201318: findings from six rounds of a national survey","volume":"380","author":"Zhang","year":"2023","journal-title":"BMJ"},{"key":"2025040709523498400_ehae670-B4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41577-019-0160-5","article-title":"Immune mechanisms of hypertension","volume":"19","author":"Drummond","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2025040709523498400_ehae670-B5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41581-019-0121-z","article-title":"Immune mechanisms of salt-sensitive hypertension and renal end-organ damage","volume":"15","author":"Mattson","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2025040709523498400_ehae670-B6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/hr.2016.35","article-title":"Hypertension as an autoimmune and inflammatory disease","volume":"39","author":"Solak","year":"2016","journal-title":"Hypertens Res"},{"key":"2025040709523498400_ehae670-B7","doi-asserted-by":"publisher","first-page":"R1089","DOI":"10.1152\/ajpregu.00373.2009","article-title":"Lymphocyte responses exacerbate angiotensin II-dependent hypertension","volume":"298","author":"Crowley","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2025040709523498400_ehae670-B8","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","article-title":"Role of the immune system in hypertension","volume":"97","author":"Rodriguez-Iturbe","year":"2017","journal-title":"Physiol Rev"},{"key":"2025040709523498400_ehae670-B9","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ Res"},{"key":"2025040709523498400_ehae670-B10","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1172\/JCI74084","article-title":"DC isoketal-modified proteins activate T cells and promote hypertension","volume":"124","author":"Kirabo","year":"2014","journal-title":"J Clin Invest"},{"key":"2025040709523498400_ehae670-B11","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.930446","article-title":"Inhibition and genetic ablation of the B7\/CD28 T-cell costimulation axis prevents experimental hypertension","volume":"122","author":"Vinh","year":"2010","journal-title":"Circulation"},{"key":"2025040709523498400_ehae670-B12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.celrep.2017.10.002","article-title":"Dendritic cell amiloride-sensitive channels mediate sodium-induced inflammation and hypertension","volume":"21","author":"Barbaro","year":"2017","journal-title":"Cell Rep"},{"key":"2025040709523498400_ehae670-B13","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(19)32135-X","article-title":"Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"394","author":"Agarwal","year":"2019","journal-title":"Lancet"},{"key":"2025040709523498400_ehae670-B14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrendo.2010.26","article-title":"Hypertension: spironolactone and resistant hypertension","volume":"6","author":"Williams","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"2025040709523498400_ehae670-B15","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1001\/jama.2014.5180","article-title":"Resistant hypertension: a review of diagnosis and management","volume":"311","author":"Vongpatanasin","year":"2014","journal-title":"JAMA"},{"key":"2025040709523498400_ehae670-B16","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1210\/jc.2003-032149","article-title":"Distinguishing the antihypertensive and electrolyte effects of eplerenone","volume":"89","author":"Levy","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040709523498400_ehae670-B17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCRESAHA.122.321228","article-title":"Smooth muscle mineralocorticoid receptor promotes hypertension after preeclampsia","volume":"132","author":"Biwer","year":"2023","journal-title":"Circ Res"},{"key":"2025040709523498400_ehae670-B18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/nm.2891","article-title":"Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors","volume":"18","author":"McCurley","year":"2012","journal-title":"Nat Med"},{"key":"2025040709523498400_ehae670-B19","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1096\/fj.09-147926","article-title":"The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure","volume":"24","author":"Nguyen Dinh","year":"2010","journal-title":"FASEB J"},{"key":"2025040709523498400_ehae670-B20","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Invest"},{"key":"2025040709523498400_ehae670-B21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"2025040709523498400_ehae670-B22","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1161\/CIRCRESAHA.116.310480","article-title":"T-cell mineralocorticoid receptor controls blood pressure by regulating interferon-gamma","volume":"120","author":"Sun","year":"2017","journal-title":"Circ Res"},{"key":"2025040709523498400_ehae670-B23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J Immunol"},{"key":"2025040709523498400_ehae670-B24","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1161\/CIRCRESAHA.121.318052","article-title":"Hypertension: do inflammation and immunity hold the key to solving this epidemic?","volume":"128","author":"Madhur","year":"2021","journal-title":"Circ Res"},{"key":"2025040709523498400_ehae670-B25","doi-asserted-by":"publisher","first-page":"H368","DOI":"10.1152\/ajpheart.00603.2016","article-title":"Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension","volume":"312","author":"Dixon","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025040709523498400_ehae670-B26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.117.312153","article-title":"Deficiency of complement C3a and C5a receptors prevents angiotensin II-induced hypertension via regulatory T cells","volume":"122","author":"Chen","year":"2018","journal-title":"Circ Res"},{"key":"2025040709523498400_ehae670-B27","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/CIRCRESAHA.119.315428","article-title":"T-cell-derived miRNA-214 mediates perivascular fibrosis in hypertension","volume":"126","author":"Nosalski","year":"2020","journal-title":"Circ Res"},{"key":"2025040709523498400_ehae670-B28","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/cvr\/cvaa257","article-title":"Role of interleukin-23\/interleukin-17 axis in T-cell-mediated actions in hypertension","volume":"117","author":"Higaki","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2025040709523498400_ehae670-B29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-\u03b2 and induction of the nuclear receptor ROR\u03b3t","volume":"9","author":"Manel","year":"2008","journal-title":"Nat Immunol"},{"key":"2025040709523498400_ehae670-B30","doi-asserted-by":"publisher","first-page":"104293","DOI":"10.1016\/j.phrs.2019.104293","article-title":"Autonomic regulation of T-lymphocytes: implications in cardiovascular disease","volume":"146","author":"Elkhatib","year":"2019","journal-title":"Pharmacol Res"},{"key":"2025040709523498400_ehae670-B31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00281-016-0590-0","article-title":"Neuroimmune interactions: dendritic cell modulation by the sympathetic nervous system","volume":"39","author":"Takenaka","year":"2017","journal-title":"Semin Immunopathol"},{"key":"2025040709523498400_ehae670-B32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1124\/jpet.104.072512","article-title":"Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse","volume":"312","author":"Iruretagoyena","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"2025040709523498400_ehae670-B33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1124\/jpet.106.103259","article-title":"Inhibition of nuclear factor-\u03baB enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis","volume":"318","author":"Iruretagoyena","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"2025040709523498400_ehae670-B34","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.4049\/jimmunol.167.7.3652","article-title":"STAT5 induces macrophage differentiation of M1 leukemia cells through activation of IL-6 production mediated by NF-\u03baB p65","volume":"167","author":"Kawashima","year":"2001","journal-title":"J Immunol"},{"key":"2025040709523498400_ehae670-B35","doi-asserted-by":"publisher","first-page":"764247","DOI":"10.3389\/fphar.2021.764247","article-title":"The effect of shionone on sepsis-induced acute lung injury by the ECM1\/STAT5\/NF-\u03baB pathway","volume":"12","author":"Song","year":"2021","journal-title":"Front Pharmacol"},{"key":"2025040709523498400_ehae670-B36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccr.2009.05.018","article-title":"Tumor suppression by phospholipase C-\u03b23 via SHP-1-mediated dephosphorylation of Stat5","volume":"16","author":"Xiao","year":"2009","journal-title":"Cancer Cell"},{"key":"2025040709523498400_ehae670-B37","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1182\/blood-2010-05-283937","article-title":"Lyn- and PLC-\u03b23-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease","volume":"116","author":"Xiao","year":"2010","journal-title":"Blood"},{"key":"2025040709523498400_ehae670-B38","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.immuni.2011.04.010","article-title":"Phospholipase C-\u03b23 regulates FcvarepsilonRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1","volume":"34","author":"Xiao","year":"2011","journal-title":"Immunity"},{"key":"2025040709523498400_ehae670-B39","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","article-title":"Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans","volume":"40","author":"Thijssen","year":"2019","journal-title":"Eur Heart J"},{"key":"2025040709523498400_ehae670-B40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00395-017-0615-4","article-title":"Role of bone marrow-derived CD11c(+) dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy","volume":"112","author":"Wang","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"2025040709523498400_ehae670-B41","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCULATIONAHA.119.045344","article-title":"CD4(+) T-cell endogenous cystathionine gamma lyase-hydrogen sulfide attenuates hypertension by sulfhydrating liver kinase B1 to promote T regulatory cell differentiation and proliferation","volume":"142","author":"Cui","year":"2020","journal-title":"Circulation"},{"key":"2025040709523498400_ehae670-B42","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.nefro.2020.11.009","article-title":"Interleukin-17A: possible mediator and therapeutic target in hypertension","volume":"41","author":"Rodrigues-Diez","year":"2021","journal-title":"Nefrologia (Engl Ed)"},{"key":"2025040709523498400_ehae670-B43","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"2025040709523498400_ehae670-B44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"2025040709523498400_ehae670-B45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","article-title":"The pathogenicity of Th17 cells in autoimmune diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin Immunopathol"},{"key":"2025040709523498400_ehae670-B46","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1101\/gad.1643908","article-title":"Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B","volume":"22","author":"Hennighausen","year":"2008","journal-title":"Genes Dev"},{"key":"2025040709523498400_ehae670-B47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1600-065X.2008.00760.x","article-title":"SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels","volume":"228","author":"Lorenz","year":"2009","journal-title":"Immunol Rev"},{"key":"2025040709523498400_ehae670-B48","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1152\/physrev.2000.80.4.1291","article-title":"Structure, function, and control of phosphoinositide-specific phospholipase C","volume":"80","author":"Rebecchi","year":"2000","journal-title":"Physiol Rev"},{"key":"2025040709523498400_ehae670-B49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"},{"key":"2025040709523498400_ehae670-B50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ahj.2017.03.011","article-title":"True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: a meta-analysis","volume":"188","author":"Vukadinovic","year":"2017","journal-title":"Am Heart J"},{"key":"2025040709523498400_ehae670-B51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1056\/NEJMe2213559","article-title":"Aldosterone and treatment-resistant hypertension","volume":"388","author":"Leopold","year":"2023","journal-title":"N Engl J Med"},{"key":"2025040709523498400_ehae670-B52","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1517\/13543784.2015.1059819","article-title":"Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease","volume":"24","author":"Liu","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"2025040709523498400_ehae670-B53","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"2025040709523498400_ehae670-B54","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"2025040709523498400_ehae670-B55","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"2025040709523498400_ehae670-B56","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/jamacardio.2023.1505","article-title":"Modifiability of composite cardiovascular risk associated with chronic kidney disease in type 2 diabetes with finerenone","volume":"8","author":"Agarwal","year":"2023","journal-title":"JAMA Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/14\/1335\/60423816\/ehae670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/14\/1335\/60423816\/ehae670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T14:26:46Z","timestamp":1744036006000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/14\/1335\/7876142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":56,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,11,5]]},"published-print":{"date-parts":[[2025,4,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae670","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4,7]]},"published":{"date-parts":[[2024,11,5]]}}}